Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myeloma

Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myeloma

Abstract Bispecific antibodies (BsAbs) have shown promise in the management of relapsed/refractory multiple myeloma (MM). Despite its efficacy, this class of drugs is associated with significant toxicities. In this study, we conducted a pooled analysis of the available clinical trials on BsAbs for t...

Full description

Saved in:
Bibliographic Details
Main Authors: Mobina Golmohammadi, Shahzad Raza, Maram Albayyadhi, Hossein Sholehrasa, Jack Khouri, Louis Williams, Doris K. Hansen, Azam Moradi, Xuan Xu, Moath Albliwi, Ali Hajj Ali, Danai Dima, Faiz Anwer, Barry Paul, Majid Jaberi-Douraki
Format: Article
Language:English
Published: Nature Publishing Group 2025-08-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-025-01334-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41408-025-01334-5

Similar Items